Results 181 to 190 of about 187,458 (237)

Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphoma [PDF]

, 2017

core   +1 more source

Bruton’s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain

Immunological Reviews, 2009
A. J. Mohamed, Li’ang Yu, C. Bäckesjö, L. Vargas, R. Faryal, R. Faryal, A. Aints, A. Aints, B. Christensson, A. Berglöf, M. Vihinen, B. Nore, C. I. Smith   +12 more
semanticscholar   +1 more source

Fenebrutinib, a Bruton's tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways. [PDF]

J Neuroinflammation
Langlois J, Lange S, Ebeling M, Macnair W, Schmucki R, Li C, DeGeer J, Sudharshan TJJ, Yong VW, Shen YA, Harp C, Collin L, Keaney J.   +12 more
europepmc   +1 more source

The Evolving Role of Bruton's Tyrosine Kinase Inhibitors in B Cell Lymphomas. [PDF]

Int J Mol Sci
Mehra S, Nicholls M, Taylor J.
europepmc   +1 more source

PROTAC for Bruton's tyrosine kinase degradation alleviates inflammation in autoimmune diseases. [PDF]

Cell Discov
Zhu C, Yang Z, Zhang Y, Li Z, Li G, Yang B, Kang N, Wang J, Sun Y, Ding N, Rao Y, Liu W.   +11 more
europepmc   +1 more source

Evaluation of Bruton's Tyrosine Kinase (BTK) inhibition with alternative doses of ibrutinib in subjects with Chronic Lymphocytic Leukemia (CLL). [PDF]

Cancer Chemother Pharmacol
Ouerdani A, Valenzuela B, Treijtel N, Haddish-Berhane N, Desphande S, Srinivasan S, Smith E, Perez Ruixo JJ.   +7 more
europepmc   +1 more source

Retraction: X-linked immunodeficient mice with no functional Bruton's tyrosine kinase are protected from sepsis-induced multiple organ failure. [PDF]

Front Immunol
Frontiers Editorial Office.
europepmc   +1 more source